EAGLE ASSET MANAGEMENT INC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$1,285,935
-56.9%
87,064
-87.6%
0.01%
-63.2%
Q2 2022$2,982,000
-34.0%
701,690
+47.7%
0.02%
-17.4%
Q1 2022$4,519,000
-48.4%
475,190
+5.0%
0.02%
-39.5%
Q4 2021$8,753,000
-42.6%
452,353
-1.3%
0.04%
-44.9%
Q3 2021$15,247,000
-53.2%
458,146
-45.4%
0.07%
-50.7%
Q2 2021$32,554,000
-20.0%
839,254
+0.9%
0.14%
-22.2%
Q1 2021$40,712,000
-42.3%
831,547
-38.7%
0.18%
-54.8%
Q4 2020$70,532,000
+82.3%
1,355,852
-8.3%
0.40%
+100.0%
Q3 2020$38,698,000
+44.1%
1,478,729
+2.3%
0.20%
+30.1%
Q2 2020$26,849,0001,445,0520.15%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 10,451,241$157,186,66542.99%
M28 Capital Management LP 339,500$5,106,0805.77%
Ghost Tree Capital, LLC 1,100,000$16,544,0004.89%
Soleus Capital Management, L.P. 750,300$11,284,5121.17%
Parkman Healthcare Partners LLC 275,641$4,145,6410.90%
683 Capital Management, LLC 775,000$11,656,0000.87%
Leucadia National 5,100,110$76,705,6540.62%
Pier Capital, LLC 233,472$3,511,4190.53%
Harvest Investment Services, LLC 40,729$612,5640.47%
Artal Group S.A. 511,389$7,6910.46%
View complete list of TG THERAPEUTICS INC shareholders